Sign in

CIK 0000939767 · Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
operating
EIN
043257395
Phone
6508377000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Grant or award President and CEO acquired 589,719 shares (grant or award)
  2. 4 Grant or award CSO/EVP Disc & Trans Research acquired 132,819 shares (grant or award)
  3. 4 Grant or award EVP & General Counsel acquired 154,070 shares (grant or award)
  4. 4 Grant or award EVP, Commercial acquired 159,383 shares (grant or award)
  5. 4 Grant or award EVP and CFO acquired 170,009 shares (grant or award)
  6. 8-K Event Executive or director change
  7. 4 Planned sale EVP, Commercial sold 10,000 shares at $38.80 ($388,000)
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. 144 Insider Sale of Securities
  10. 4 Open-market sale Director sold 73,808 shares at an average $38.00 ($2,804,459)
  11. 4 Grant or award President and CEO acquired 184,909 shares (grant or award)
  12. 4 Grant or award CSO/EVP Disc & Trans Research acquired 49,209 shares (grant or award)
  13. 4 Grant or award EVP, Commercial acquired 47,718 shares (grant or award)
  14. 4 Grant or award EVP & General Counsel acquired 52,192 shares (grant or award)
  15. 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 52,192 shares (grant or award)
  16. 4 Planned sale Director sold 8,768 shares at $37.80 ($331,430)
  17. 4 Grant or award EVP and CFO acquired 59,648 shares (grant or award)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 4 Open-market sale EVP, Commercial sold 52,636 shares at $36.98 ($1,946,479)

Page 9 of 126 · 2,517 filings